Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josep Julve

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Atherosclerosis|March 29, 2014
Bariatric surgery in morbidly obese patients improves the atherogenic qualitative properties of the plasma lipoproteinsJosep Julve, Eva Pardina, Montserrat Pérez-Cuéllar, et al.
Revista Espanola De Cardiologia (English Ed.)|October 30, 2021
<sup>1</sup>H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controlsAlbert Teis, Esmeralda Castelblanco, Germán Cediel, et al.
Cardiovascular Diabetology|March 6, 2026
Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal studyÁngel Rosales-Rojas, Albert Teis, Pedro Gil-Millan, et al.
Molecular Nutrition & Food Research|June 12, 2013
Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transportJosep Julve, Joan C Escolà-Gil, Elisabeth Rodríguez-Millán, et al.
Nutrients|March 28, 2026
Niacin Derivatives in MASLD: Metabolic and Therapeutic InsightsMarina Idalia Rojo-López, Julia Niño-Narvión, Maria Antentas, et al.
Journal of Clinical Medicine|February 13, 2025
Low-Density Lipoprotein Subfraction Phenotype Is Associated with Epicardial Adipose Tissue Volume in Type 2 DiabetesJosé Rives, Pedro Gil-Millan, David Viladés, et al.
Frontiers in Cellular and Infection Microbiology|April 2, 2024
Modulatory actions of <i>Echinococcus granulosus</i> antigen B on macrophage inflammatory activationAna Maite Folle, Sofía Lagos Magallanes, Martín Fló, et al.
Journal of Clinical Medicine|July 12, 2025
Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients: Effect of Metabolic ControlPedro Gil-Millan, José Rives, David Viladés, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2022
MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transportMiguel Hueso, Raquel Griñán, Adrián Mallen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013
Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expressionMónica Pascual-García, Laura Rué, Theresa León, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Atherosclerosis|March 29, 2014
Bariatric surgery in morbidly obese patients improves the atherogenic qualitative properties of the plasma lipoproteinsJosep Julve, Eva Pardina, Montserrat Pérez-Cuéllar, et al.
Revista Espanola De Cardiologia (English Ed.)|October 30, 2021
<sup>1</sup>H-magnetic resonance spectroscopy lipoprotein profile in patients with chronic heart failure versus matched controlsAlbert Teis, Esmeralda Castelblanco, Germán Cediel, et al.
Cardiovascular Diabetology|March 6, 2026
Impact of glycemic optimization on myocardial steatosis and cardiac remodeling in patients with newly diagnosed type 2 diabetes: a longitudinal studyÁngel Rosales-Rojas, Albert Teis, Pedro Gil-Millan, et al.
Molecular Nutrition & Food Research|June 12, 2013
Methionine-induced hyperhomocysteinemia impairs the antioxidant ability of high-density lipoproteins without reducing in vivo macrophage-specific reverse cholesterol transportJosep Julve, Joan C Escolà-Gil, Elisabeth Rodríguez-Millán, et al.
Nutrients|March 28, 2026
Niacin Derivatives in MASLD: Metabolic and Therapeutic InsightsMarina Idalia Rojo-López, Julia Niño-Narvión, Maria Antentas, et al.
Journal of Clinical Medicine|February 13, 2025
Low-Density Lipoprotein Subfraction Phenotype Is Associated with Epicardial Adipose Tissue Volume in Type 2 DiabetesJosé Rives, Pedro Gil-Millan, David Viladés, et al.
Frontiers in Cellular and Infection Microbiology|April 2, 2024
Modulatory actions of <i>Echinococcus granulosus</i> antigen B on macrophage inflammatory activationAna Maite Folle, Sofía Lagos Magallanes, Martín Fló, et al.
Journal of Clinical Medicine|July 12, 2025
Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients: Effect of Metabolic ControlPedro Gil-Millan, José Rives, David Viladés, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2022
MiR-125b downregulates macrophage scavenger receptor type B1 and reverse cholesterol transportMiguel Hueso, Raquel Griñán, Adrián Mallen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2013
Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expressionMónica Pascual-García, Laura Rué, Theresa León, et al.
Pageof 13